Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration-resistant prostate cancer receiving abiraterone acetate: An evidence-based case report and review of literature

Oliver E. Yausep; Raksheeth Agarwal; Rifqha Aulina; Anthony E. Wijaya; Ilonka Amaia; Addina W. Moekti; Ikhwan Rinaldi; Agus Rizal A.H. Hamid

doi:10.1002/ccr3.2288

Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration-resistant prostate cancer receiving abiraterone acetate: An evidence-based case report and review of literature

Oliver E. Yausep
, Raksheeth Agarwal
, Rifqha Aulina
, Anthony E. Wijaya
, Ilonka Amaia
, Addina W. Moekti
, Ikhwan Rinaldi
, Agus Rizal A.H. Hamid

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Platelet to lymphocyte ratio (PLR) is a candidate prognostic marker for metastatic castration-resistant prostate cancer patients receiving abiraterone acetate and evidence demonstrates that a high PLR is associated with poor survival. More studies are required to verify current findings and establish a definite cutoff point.

Original language	English
Pages (from-to)	1585-1590
Number of pages	6
Journal	Clinical Case Reports
Volume	7
Issue number	8
DOIs	https://doi.org/10.1002/ccr3.2288
Publication status	Published - 1 Jan 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

abiraterone
lymphocyte
metastatic Castration-Resistant Prostate Cancer
platelet
platelet to lymphocyte ratio
prostate cancer

Access to Document

10.1002/ccr3.2288

Fingerprint

Dive into the research topics of 'Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration-resistant prostate cancer receiving abiraterone acetate: An evidence-based case report and review of literature'. Together they form a unique fingerprint.

Cite this

Yausep, O. E., Agarwal, R., Aulina, R., Wijaya, A. E., Amaia, I., Moekti, A. W., Rinaldi, I., & Hamid, A. R. A. H. (2019). Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration-resistant prostate cancer receiving abiraterone acetate: An evidence-based case report and review of literature. Clinical Case Reports, 7(8), 1585-1590. https://doi.org/10.1002/ccr3.2288

@article{bcd4ea1ae2f0440ca38434f51099b262,

title = "Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration-resistant prostate cancer receiving abiraterone acetate: An evidence-based case report and review of literature",

abstract = "Platelet to lymphocyte ratio (PLR) is a candidate prognostic marker for metastatic castration-resistant prostate cancer patients receiving abiraterone acetate and evidence demonstrates that a high PLR is associated with poor survival. More studies are required to verify current findings and establish a definite cutoff point.",

keywords = "abiraterone, lymphocyte, metastatic Castration-Resistant Prostate Cancer, platelet, platelet to lymphocyte ratio, prostate cancer",

author = "Yausep, \{Oliver E.\} and Raksheeth Agarwal and Rifqha Aulina and Wijaya, \{Anthony E.\} and Ilonka Amaia and Moekti, \{Addina W.\} and Ikhwan Rinaldi and Hamid, \{Agus Rizal A.H.\}",

note = "Publisher Copyright: {\textcopyright} 2019 The Authors. Clinical Case Reports published by John Wiley \& Sons Ltd.",

year = "2019",

month = jan,

day = "1",

doi = "10.1002/ccr3.2288",

language = "English",

volume = "7",

pages = "1585--1590",

journal = "Clinical Case Reports",

issn = "2050-0904",

publisher = "John Wiley and Sons Ltd",

number = "8",

}

Yausep, OE, Agarwal, R, Aulina, R, Wijaya, AE, Amaia, I, Moekti, AW, Rinaldi, I & Hamid, ARAH 2019, 'Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration-resistant prostate cancer receiving abiraterone acetate: An evidence-based case report and review of literature', Clinical Case Reports, vol. 7, no. 8, pp. 1585-1590. https://doi.org/10.1002/ccr3.2288

Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration-resistant prostate cancer receiving abiraterone acetate: An evidence-based case report and review of literature. / Yausep, Oliver E.; Agarwal, Raksheeth; Aulina, Rifqha et al.
In: Clinical Case Reports, Vol. 7, No. 8, 01.01.2019, p. 1585-1590.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration-resistant prostate cancer receiving abiraterone acetate

T2 - An evidence-based case report and review of literature

AU - Yausep, Oliver E.

AU - Agarwal, Raksheeth

AU - Aulina, Rifqha

AU - Wijaya, Anthony E.

AU - Amaia, Ilonka

AU - Moekti, Addina W.

AU - Rinaldi, Ikhwan

AU - Hamid, Agus Rizal A.H.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Platelet to lymphocyte ratio (PLR) is a candidate prognostic marker for metastatic castration-resistant prostate cancer patients receiving abiraterone acetate and evidence demonstrates that a high PLR is associated with poor survival. More studies are required to verify current findings and establish a definite cutoff point.

AB - Platelet to lymphocyte ratio (PLR) is a candidate prognostic marker for metastatic castration-resistant prostate cancer patients receiving abiraterone acetate and evidence demonstrates that a high PLR is associated with poor survival. More studies are required to verify current findings and establish a definite cutoff point.

KW - abiraterone

KW - lymphocyte

KW - metastatic Castration-Resistant Prostate Cancer

KW - platelet

KW - platelet to lymphocyte ratio

KW - prostate cancer

UR - https://www.scopus.com/pages/publications/85070628200

U2 - 10.1002/ccr3.2288

DO - 10.1002/ccr3.2288

M3 - Article

AN - SCOPUS:85070628200

SN - 2050-0904

VL - 7

SP - 1585

EP - 1590

JO - Clinical Case Reports

JF - Clinical Case Reports

IS - 8

ER -

Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration-resistant prostate cancer receiving abiraterone acetate: An evidence-based case report and review of literature

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this